Fabiana Pirani Carneiro

Dr. Fabiana Pirani Carneiro


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 September 2009 in Parasite Immunology
Verified
Journal Article
Closed access
PDF file
FCFabiana Pirani Carneiro
Fabiana Pirani Carneiro
AMA. V. DE Magalhães
A. V. DE Magalhães
MCM. DE Jesus Abreu Almeida Couto
M. DE Jesus Abreu Almeida Couto
ABAnamelia Bocca
Anamelia Bocca
MMMaria Muniz-Junqueira
Maria Muniz-Junqueira
RSR. N. Ribeiro Sampaio
R. N. Ribeiro Sampaio

17 October 2014 in Journal of Cancer Research and Clinical Oncology
Verified
Journal Article
Closed access
PDF file
EDEmanuel Adelino M. Damasceno
Emanuel Adelino M. Damasceno
FCFabiana Pirani Carneiro
Fabiana Pirani Carneiro
AMAlbino Verçosa de Magalhães
Albino Verçosa de Magalhães
MCMarcos de Vasconcelos Carneiro
Marcos de Vasconcelos Carneiro
GTGustavo Henrique Soares Takano
Gustavo Henrique Soares Takano
AMAndrea Barreto Motoyama
Andrea Barreto Motoyama

30 September 2009 in Diagnostic Microbiology and Infectious Disease
Verified
Journal Article
Closed access
FCFabiana Pirani Carneiro
Fabiana Pirani Carneiro
LMLívia Bravo Maia
Lívia Bravo Maia
MMMário Augusto P. Moraes
Mário Augusto P. Moraes
AMAlbino Verçosa de Magalhães
Albino Verçosa de Magalhães
LVLeonora Maciel de S. Vianna
Leonora Maciel de S. Vianna
CRCarmélia Matos Reis
Carmélia Matos Reis

1 August 2007 in Revista da Sociedade Brasileira de Medicina Tropical
Verified
Journal Article
Open access
PDF file
FCFabiana Pirani Carneiro
Fabiana Pirani Carneiro
MMMário Augusto P. Moraes
Mário Augusto P. Moraes
ARAna Maria G. Rebêlo
Ana Maria G. Rebêlo
ACAmália M. Coutinho
Amália M. Coutinho
Descreve-se um caso de prototecose cutânea em paciente de 78 anos, submetido a tratamento para pênfigo foliáceo e feohifomicose. Ele apresentava lesões eritematosas infiltradas na perna direita e o diagnóstico foi feito através de estudo histológico e através de cultura da pele lesada. A cura foi obtida com o uso oral de itraconazol.

1 January 2020 in BioMed Research International
Verified
Journal Article
Open access
PDF file
FCFabiana Pirani Carneiro
Fabiana Pirani Carneiro
ADAndersen Charles Darós
Andersen Charles Darós
ADAdriana Cysneiro Milhomem Darós
Adriana Cysneiro Milhomem Darós
TCTércia Maria Mendes Lousa de Castro
Tércia Maria Mendes Lousa de Castro
MCMarcos de Vasconcelos Carneiro
Marcos de Vasconcelos Carneiro
AMAndrea Barretto Motoyama
Andrea Barretto Motoyama
Introduction. Despite increasing application of molecular diagnostic methods for the detection of sexually transmitted infections, the cytological findings in pap smears of patients with pathogens that can be identified only by PCR are not yet well described. The aim of this study was to describe the most common cytological features in cervical pap smears of patients with Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium, Trichomonas vaginalis, Mycoplasma hominis, Ureaplasma urealyticum, and Ureaplasma parvum detected by multiplex PCR. Methods. Cervical samples for conventional and liquid‐based cytology and for multiplex PCR were collected from women ranging from 23 to 54 years old, who underwent routine screening at a gynecological Unit. Results. Multiplex PCR was positive in 36.2% of the samples: Ureaplasma parvum 14.9%, Chlamydia trachomatis 10.6%, Trichomonas vaginalis 10.6%, Mycoplasma hominis 8.5%, Ureaplasma urealyticum 4.2%, Neisseria gonorrhoeae 2.1%, and Mycoplasma genitalium (0). Multiple pathogens were observed in 12.8% of samples. Microscopic cervicitis (≥10 polymorphonuclear leukocytes/epithelial cell) and normal (predominantly lactobacillary) microbiota were the most frequent findings in the samples in which the pathogens were detected alone or in multiple infections, except for samples with Trichomonas vaginalis in which the coccobacillary microbiota was the most common. In samples with microscopic cervicitis and normal microbiota, those with at least one pathogen identified by multiplex PCR were significantly more frequent than those with no pathogen, 66.6% versus 33.3%. Conclusion. Failure to identify an inflammatory agent in pap smear with intense neutrophil exudate may suggest the presence of Ureaplasma parvum, Ureaplasma urealyticum, Chlamydia trachomatis, or Trichomonas vaginalis. A remark on the intensity of inflammation should be made in the reports of cervical pap smears so that this cytological finding can be correlated with clinical and PCR results.

12 June 2019 in Oncology Letters
Verified
Journal Article
Open access
PDF file
FCFabiana Pirani Carneiro
Fabiana Pirani Carneiro
MMMaria Muniz-Junqueira
Maria Muniz-Junqueira
MCMarcos de Vasconcelos Carneiro
Marcos de Vasconcelos Carneiro
GTGustavo Henrique Soares Takano
Gustavo Henrique Soares Takano
LVLeonora Maciel de Sousa Vianna
Leonora Maciel de Sousa Vianna
VFVânia Moraes Ferreira
Vânia Moraes Ferreira
Epithelial cell adhesion molecule (EpCAM) has been used as diagnostic/prognostic marker and therapeutic target. The aim of the present study was to compare immunoreactivity of antibodies against distinct epitopes in the ectodomain of EpCAM for detection of carcinoma from different primary sites and of different histological types in effusions and peritoneal wash. Two antibodies against epitopes in the EGF‑like domain I (clones Moc‑31 and Ber‑EP4) and one antibody against the epitope in the cysteine‑poor region (158210) of EpCAM were used (all commercially available). Independently of the clone used, EpCAM overexpression was observed in almost all samples when all the adenocarcinoma samples were analyzed together. By using Moc‑31, EpCAM overexpression was observed in all samples of adenocarcinoma. Absence of EpCAM overexpression was observed in a few adenocarcinoma samples at some sites of tumor origin, including ovary, breast and stomach, when Ber‑EP4 and 158210 were used. Regarding carcinomas aside from adenocarcinomas, histological types, such as squamous cell, urothelial and small cell carcinoma showed different degrees of EpCAM expression according to the antibody used. In squamous cell carcinoma, overexpression was observed only with the clone 158210. It was concluded that, overall, most samples of metastatic carcinoma from effusions showed overexpression of EpCAM. However, there are significant variations in its detection according to the primary site, histological type of the carcinoma and depending on the antibody used. Thus, the use of more than one type of anti‑EpCAM antibody would increase the chance of its detection in metastatic carcinoma effusion.